GlycoMimetics Inc. (GLYC)
NASDAQ: GLYC
· Real-Time Price · USD
15.71
-0.44 (-2.72%)
At close: Jul 02, 2025, 3:58 PM
GlycoMimetics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 54.09K | 54.09K | 54.09K | 10K | 10K | 10K | 10K | 75.00 | 75.00 | 75.08K | 75.08K | 93K | 179.56K | 104.7K | 1.16M | 1.31M | 2.22M | 2.22M |
Cost of Revenue | 8.13K | 8.13K | 8.13K | 31.43K | 293.23K | 559.1K | 822.06K | 1.06M | 1.04M | 1.04M | 1.03M | 789.57K | 533.54K | 275.1K | 16.98K | n/a | n/a | n/a |
Gross Profit | 18.91K | 18.91K | 18.91K | -21.43K | -283.23K | -549.1K | -812.06K | -1.06M | -1.04M | -961.92K | -957.08K | -696.57K | -353.98K | -170.4K | 1.14M | 1.31M | 2.22M | 2.22M |
Operating Income | -42M | -31.32M | -40.04M | -42.3M | -40.88M | -39.45M | -39.28M | -40.31M | -39.26M | -43.68M | -47.4M | -54.21M | -62.78M | -63.83M | -63.45M | -61.59M | -57.98M | -57.68M |
Interest Income | 662.77K | 612.05K | 935.27K | 1.34M | 1.76M | 2.17M | 2.38M | 2.24M | 1.87M | 1.29M | 714.52K | 340.33K | 101.36K | 20.99K | 19.77K | 21.3K | 21.44K | 42.92K |
Pretax Income | -19.39M | -29.49M | -37.88M | -39.73M | -39.11M | -37.28M | -36.9M | -38.07M | -37.39M | -42.4M | -46.69M | -53.87M | -62.68M | -63.81M | -63.43M | -61.57M | -57.96M | -57.64M |
Net Income | -19.39M | -29.49M | -37.88M | -39.74M | -39.11M | -37.28M | -36.32M | -56.45M | -55.53M | -60.45M | -65.32M | -53.53M | -62.58M | -63.8M | -63.43M | -61.57M | -57.96M | -57.64M |
Selling & General & Admin | 20.42M | 15.54M | 18.25M | 17.48M | 18M | 18.78M | 19.21M | 19.63M | 18.96M | 19.55M | 19.09M | 18.9M | 19.2M | 17.98M | 17.11M | 16.58M | 16.49M | 16.49M |
Research & Development | 14.04M | 8.25M | 14.26M | 19.32M | 5.31B | 5.31B | 5.31B | 5.31B | 20.31M | 24.21M | 28.39M | 35.4M | 43.75M | 45.95M | 47.49M | 46.32M | 43.7M | 43.41M |
Other Expenses | 7.53M | 7.53M | 7.53M | 5.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 42M | 31.32M | 40.04M | 42.31M | 40.89M | 39.46M | 39.28M | 40.31M | 39.26M | 43.76M | 47.48M | 54.3M | 62.96M | 63.93M | 64.61M | 62.89M | 60.2M | 59.9M |
Interest Expense | -1.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 143.00 | 183.00 | 183.00 | 183.00 | 40.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.97M | 31.32M | 40.04M | 42.31M | 40.89M | 39.46M | 39.28M | 40.31M | 39.26M | 43.76M | 47.48M | 54.3M | 62.96M | 63.93M | 64.61M | 62.89M | 60.2M | 59.9M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -581.36K | 18.38M | 18.14M | 18.05M | 18.63M | -336.55K | -93.05K | -6.78K | 404.00 | 1.17K | 324.00 | -443 |
Shares Outstanding (Basic) | 3.86B | 64.52M | 64.48M | 64.48M | 64.48M | 64.46M | 64.39M | 64.35M | 64.28M | 60.35M | 52.96M | 52.42M | 52.41M | 52.33M | 52.01M | 51.56M | 51.54M | 50.7M |
Shares Outstanding (Diluted) | 3.86B | 64.52M | 64.48M | 64.48M | 64.48M | 64.46M | 64.39M | 64.35M | 64.28M | 60.35M | 52.96M | 52.42M | 52.41M | 52.33M | 52.01M | 51.56M | 51.54M | 50.7M |
EPS (Basic) | -4.93K | -0.46 | -0.59 | -0.62 | -0.61 | -0.58 | -0.57 | -0.98 | -1 | -1.12 | -1.24 | -1.02 | -1.2 | -1.23 | -1.23 | -1.23 | -1.18 | -1.22 |
EPS (Diluted) | -4.93K | -0.46 | -0.59 | -0.62 | -0.61 | -0.58 | -0.57 | -0.98 | -1 | -1.12 | -1.24 | -1.02 | -1.2 | -1.23 | -1.23 | -1.22 | -1.17 | -1.21 |
EBITDA | -34.46M | -23.77M | -32.47M | -36.73M | -40.78M | -39.32M | -39.12M | -40.13M | -39.08M | -43.49M | -47.2M | -53.98M | -62.53M | -63.57M | -63.18M | -61.32M | -57.71M | -57.41M |
EBIT | -13.43M | -23.79M | -32.51M | -36.78M | -40.88M | -39.45M | -39.27M | -40.31M | -39.26M | -43.68M | -47.4M | -54.21M | -62.78M | -63.83M | -63.45M | -61.59M | -57.98M | -57.68M |
Depreciation & Amortization | -27.04K | -14.62K | n/a | 58.47K | 93.09K | 124.08K | 372.42K | 608.69K | 821.97K | 1.04M | 1.03M | 1.03M | 1.03M | 1.02M | 1.01M | 826.27K | 635.98K | 451.24K |